{"count":42,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+5343&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/db9eadc1-42de-444d-85eb-7d9478453c88/","filing_uuid":"db9eadc1-42de-444d-85eb-7d9478453c88","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/db9eadc1-42de-444d-85eb-7d9478453c88/print/","filing_document_content_type":"text/html","income":null,"expenses":"75000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Maynard Friesz","dt_posted":"2026-04-01T21:02:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Commerce Dr","registrant_address_2":"Suite 90","registrant_different_address":true,"registrant_city":"Schaumburg","registrant_state":"IL","registrant_zip":"60173","registrant":{"id":401104586,"url":"https://lda.gov/api/v1/registrants/401104586/","house_registrant_id":null,"name":"CURE SMA","description":"Non-profit","address_1":"50 Commerce Dr","address_2":"Suite 90","address_3":null,"address_4":null,"city":"Schaumburg","state":"IL","state_display":"Illinois","zip":"60173","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAYNARD FRIESZ","contact_telephone":"+1 202-871-8004","dt_updated":"2026-07-10T12:05:55.658081-04:00"},"client":{"id":202103,"url":"https://lda.gov/api/v1/clients/202103/","client_id":12,"name":"CURE SMA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-08-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Research into spinal muscular atrophy, timely access to care, treatments, medical devices, and home and community-based services, Give Kids a Chance Act (H.R.1261/ S.932- FDA Pediatric Priority Review Voucher Program), DOD Congressionally Directed Medical Research Program & Peer-Reviewed Medical Research Program, Labor-Health and Human Services, and Education Appropriations bill, Family Caregiver Awareness, Resources, and Education (CARE) Partnerships Act, Pediatric Palliative Care Homes, National Institute on Disability, Independent Living, and Rehabilitation Research funding, Seat Elevation in Group 2 Non-Complex Power Wheelchairs, Coverage of Standing Systems in Group 3 Power Wheelchair, Competitive Bidding for Tracheostomy, Ostomy and Urological Supplies; FDA Rare Disease Patient Listening Session, Coverage of Respiratory Assist Devices (RADs) and Home Mechanical Ventilators (HMVs), Accelerating Kids Access to Care Act (H.R. 1509/S. 752, National Institutes of Health funding; Medicaid home and community-based services, Public Law 119-21 Medicaid Community Engagement Requirements - disability and medically frail definition; Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343), Veterans STAND Act (H.R. 6835), Veterans SPORTS Act (S. 3138) Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health research into spinal muscular atrophy, U.S. Department of Defense Peer-Reviewed Medical Research in spinal muscular atrophy, Congressionally Directed Medical Research Program funding, Medicaid home and community-based services, housing (Sec. 811 Housing for People with Disabilities & Mainstream Housing Choice Vouchers), Defense Health Research Programs (Congressionally Directed Medical Research Programs), National Institute on Disability, Independent Living, and Rehabilitation Research funding, Labor-HHS-Education Appropriations bill, Transportation-HUD Appropriations bill, Defense Appropriations bill, Department of Education Office of Special Education and Rehabilitative Services staffing, Consolidated Appropriations Act of 2026 (P.L. 119-75), Assistive Technology Act program funding, Access Board funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":35,"name":"Housing & Urban Development, Dept of (HUD)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Supplemental Security Income Savings Penalty Elimination Act (H.R.2540/ S.1234), SSI Restoration Act, disability marriage penalty, Marriage Equality for Disabled Adults Act (H.R. 1389), Eliminating the Marriage Penalty in SSI Act (H.R. 320/ S.73), home and community-based services, Individuals with Disabilities Act (P.L. 101-336), ENABLE Act (H.R.1436/S.627), Seat Elevation in Group 2 Non-Complex Power Wheelchairs, Coverage of Standing Systems in Power Wheelchairs, Adult Changing Tables at U.S. Capitol, Department of Education Office of Special Education and Rehabilitative Services staffing and enforcement, Public Law 119-21 Implementation, including disability and medically frail definition for Medicaid Community Engagement Requirement; Veterans STAND Act (H.R. 6835), Veterans SPORTS Act (S. 3138), ABLE Tomorrow Act, the ABLE MATCH Act, and the ABLE Direct Deposit Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AVI","general_issue_code_display":"Aviation/Airlines/Airports","description":"FAA Reauthorization Act of 2024 (P.L. 118-63); Air Carrier Access Act (P.L. 99-435), Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Final Rule, \"Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Rule II, Transportation-HUD Appropriations bill, disability-related air travel complaints & aviation consumer protections","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"U.S. Department of Defense Peer-Reviewed Medical Research Program Research in Spinal Muscular Atrophy, Funding for Defense Health Research Programs (Congressionally Directed Medical Research Programs and Peer Reviewed Medical Research Program), Medical Research for Our Troops Act (H.R. 3906)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"Transportation-HUD Appropriations bill, housing for people with disabilities (Sec. 811 Housing for People with Disabilities & Mainstream Housing Choice Vouchers), funding for disability and aging programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":35,"name":"Housing & Urban Development, Dept of (HUD)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"medical research in spinal muscular atrophy, development and approval of spinal muscular atrophy treatments, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, U.S. Department of Defense Congressionally Directed Medical Research Program funding, Medical Research for Our Troops Act (H.R. 3906)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid home and community-based services, Medicaid caregiving services, Medicaid funding, 2025 Budget Resolution, durable medical equipment, Pediatric Palliative Care Homes, H.R. 1, Think Differently Database Act (P.L. 118-225), Labor-HHS-Education Appropriations bill, Public Law 119-21 Implementation, including disability and medically frail definition for Medicaid Community Engagement Requirement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"ENABLE Act (H.R.1436/ S.627), Mobility Means Freedom Act (H.R.2320), Achieving a Better Life Experience (ABLE) Act (P.L. 113-295), H.R. 1, ABLE Tomorrow Act, the ABLE MATCH Act, and the ABLE Direct Deposit Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"FAA Reauthorization Act of 2024 (P.L. 118-63); Air Carrier Access Act (P.L. 99-435), Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Final Rule, Disability Access to Transportation Act, accessibility in community transportation, Automated Vehicle (AV) Deployment and Research, Transportation-HUD Appropriations bill, surface transportation reauthorization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Labor, Health and Human Services, and Education Appropriations bill; IDEA Full Funding Act (H.R.2598/ S.1277), IDEA enforcement and oversight, Department of Education Office of Special Education and Rehabilitative Services staffing and enforcement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Disaster Relief Medicaid Act (H.R.3990/ S.2071), disaster planning and readiness assistance for individuals with disabilities","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d8392d65-6413-47f9-81e3-45f6f90ce49c/","filing_uuid":"d8392d65-6413-47f9-81e3-45f6f90ce49c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/d8392d65-6413-47f9-81e3-45f6f90ce49c/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ronald M. Jacobs, Partner","dt_posted":"2026-04-09T20:10:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Massachusetts Avenue NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":39941,"url":"https://lda.gov/api/v1/registrants/39941/","house_registrant_id":31958,"name":"VENABLE LLP","description":"Law firm","address_1":"600 Massachusetts Avenue NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RONALD M. JACOBS","contact_telephone":"+1 202-344-4000","dt_updated":"2026-07-27T16:10:38.817219-04:00"},"client":{"id":60689,"url":"https://lda.gov/api/v1/clients/60689/","client_id":60689,"name":"ASSOCIATION OF BLACK CARDIOLOGISTS","general_description":"Nonprofit organization","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-06-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to care and improving cardiovascular health Continuing Resolution, H.R. 1968 The Treat and Reduce Obesity Act (TROA), H.R. 4818 / S. 2407; The HEARTS Act, H.R. 6829; H.R. 307, the ARC Act of 2025; H.R. 1672, the Maintaining Investments in New Innovation (MINI) Act; FY27 Appropriations Bill; H.R. 7417, Women's Heart Health Expansion Act of 2026; H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":133401,"prefix":null,"prefix_display":null,"first_name":"ILISA","nickname":null,"middle_name":null,"last_name":"HALPERN PAUL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":98708,"prefix":null,"prefix_display":null,"first_name":"YARDLY","nickname":null,"middle_name":null,"last_name":"POLLAS-KIMBLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/76bd107c-d9f3-4d65-a60c-8876ffe501a3/","filing_uuid":"76bd107c-d9f3-4d65-a60c-8876ffe501a3","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/76bd107c-d9f3-4d65-a60c-8876ffe501a3/print/","filing_document_content_type":"text/html","income":null,"expenses":"160000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brenna Leamer","dt_posted":"2026-04-15T11:32:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"901 F St., NW Suite 610","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":18411,"url":"https://lda.gov/api/v1/registrants/18411/","house_registrant_id":31167,"name":"F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES","description":null,"address_1":"901 F St., NW Suite 610","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENNA LEAMER","contact_telephone":"+1 317-282-3252","dt_updated":"2026-07-15T13:50:56.942960-04:00"},"client":{"id":123844,"url":"https://lda.gov/api/v1/clients/123844/","client_id":12,"name":"F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Access to and reimbursement of diagnostics in the Medicare program. H.R. 5269 / S. 2761 Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare reimbursement of Clinical Laboratory Fee Schedule (CLFS), specifically reforms to address payment cuts resulting from the Protecting Access to Medicare Act (PAMA) 2014. S.1717 / H.R.5343 The Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing transitional coverage period. Issues related to Tariffs and Department of Commerce 232 investigation on Medical Technologies FY2027 Appropriations for Labor, Health and Human Services, Education, and Related Agencies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"(FOR) HIV Testing in the President's Emergency Plan for AIDS Relief, including funding to support PEPFAR laboratory services and testing in FY2027 Appropriations for National Security, Department of State, and Related Programs, and PEPFAR Reauthorization in the FY2026 State Department Reauthorization (H.R.5300 - Department of State Policy Provisions Act)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Alzheimer's and Influenza Preparedness Clinical Lab Fee Schedule reform, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act H.R. 5269 / S. 2761 and Medicare coverage of FDA approved breakthrough diagnostics, S.1717 / H.R. 5343 The Ensuring Patient Access to Critical Breakthrough","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/24fda7a4-5006-4010-84e6-2027fe78cefa/","filing_uuid":"24fda7a4-5006-4010-84e6-2027fe78cefa","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/24fda7a4-5006-4010-84e6-2027fe78cefa/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Greg D'Angelo","dt_posted":"2026-04-15T16:17:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":61144,"url":"https://lda.gov/api/v1/clients/61144/","client_id":61144,"name":"ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)","general_description":"Medical technology trade association.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues relates to Medicare coverage of breakthrough technologies. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6a4041ff-a24b-4580-9dc7-b78e16cdb9fb/","filing_uuid":"6a4041ff-a24b-4580-9dc7-b78e16cdb9fb","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6a4041ff-a24b-4580-9dc7-b78e16cdb9fb/print/","filing_document_content_type":"text/html","income":null,"expenses":"200000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Allison Giles","dt_posted":"2026-04-17T13:54:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"P.O. Box 6924","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22206","registrant":{"id":87654,"url":"https://lda.gov/api/v1/registrants/87654/","house_registrant_id":36626,"name":"THE COOK GROUP INC.","description":"Medical device manufacturer.","address_1":"P.O. Box 6924","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22206","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALLISON GILES","contact_telephone":"+1 202-631-5577","dt_updated":"2026-07-21T16:23:20.759644-04:00"},"client":{"id":173616,"url":"https://lda.gov/api/v1/clients/173616/","client_id":12,"name":"THE COOK GROUP INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Graduate Medical Education (GME): -\"Resident Physician Shortage Reduction Act of 2025\" (H.R. 4731) which would increase GME positions in rural areas; -the \"Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025\" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Workforce Development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SPO","general_issue_code_display":"Sports/Athletics","description":"Name, Image and Likeness (NIL) issue: \"SCORE Act\" (H.R. 4312)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities Medicare payment for FTE residents training in rural areas, \"Rural Physician Workforce Production Act of 2025\" (H.R. 1153)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CHM","general_issue_code_display":"Chemicals/Chemical Industry","description":"PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/43334512-5149-4810-8fab-f915b0e23f46/","filing_uuid":"43334512-5149-4810-8fab-f915b0e23f46","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/43334512-5149-4810-8fab-f915b0e23f46/print/","filing_document_content_type":"text/html","income":null,"expenses":"642000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Steven LaPierre","dt_posted":"2026-04-20T08:14:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 PENNSYLVANIA AVENUE, NW","registrant_address_2":"SUITE 925","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":66716,"url":"https://lda.gov/api/v1/registrants/66716/","house_registrant_id":35567,"name":"BOSTON SCIENTIFIC CORPORATION","description":null,"address_1":"1455 PENNSYLVANIA AVENUE, NW","address_2":"SUITE 925","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVEN N. LAPIERRE","contact_telephone":"","dt_updated":"2026-07-24T11:29:57.860946-04:00"},"client":{"id":163613,"url":"https://lda.gov/api/v1/clients/163613/","client_id":12,"name":"BOSTON SCIENTIFIC CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2001-06-01"},"lobbying_activities":[{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communities Act - Advocacy for reauthorization of the SUPPORT Act, specifically for FDA approved alternative treatments for Chronic Pain, and medical devices role to address the opioid epidemic. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Supply Chain - advocacy efforts on topics that could potentially impact the medical device supply chain such as decisions made by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, outbound investments, raw materials, components, export controls, and shortage/supply chain resiliency reporting regulations. Submitted comments for the U.S. Dept of Commerce's investigation to determine the effects on the national security of imports of medical equipment including medical devices. Discussed the unique aspects and critical contributions of the U.S. medical technology sector as related to tariffs and other trade measures on imported medical devices and components and our support for policies that do not harm domestic manufacturing and global competition in the sector.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"EPA Rulemaking Restricting Ethylene Oxide (ETO) - Proposed rulemaking to place more-stringent limits on emissions and institute new monitoring requirements for ethylene oxide (ETO). Advocacy efforts include educating lawmakers on the importance of ETO in the sterilization of medical devices and potential shortages of sterile medical devices if EPA's proposed changes are enacted.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/73eeb6bc-e2db-4118-88e0-aedf6c74ffff/","filing_uuid":"73eeb6bc-e2db-4118-88e0-aedf6c74ffff","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/73eeb6bc-e2db-4118-88e0-aedf6c74ffff/print/","filing_document_content_type":"text/html","income":null,"expenses":"1100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Greg Crist","dt_posted":"2026-04-20T10:47:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1301 PENNSYLVANIA AVENUE, N.W., SUITE 400","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":17831,"url":"https://lda.gov/api/v1/registrants/17831/","house_registrant_id":31001,"name":"ADVANCED MEDICAL TECHNOLOGY ASSN","description":null,"address_1":"1301 PENNSYLVANIA AVENUE, N.W., SUITE 400","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG CRIST","contact_telephone":"+1 202-434-7240","dt_updated":"2026-07-30T14:15:38.691802-04:00"},"client":{"id":123312,"url":"https://lda.gov/api/v1/clients/123312/","client_id":12,"name":"ADVANCED MEDICAL TECHNOLOGY ASSN","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to appropriations and user fee funding for the Food and Drug Administration","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to small business taxes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5db282f-c2da-4316-8025-04d4c1e69e42/","filing_uuid":"b5db282f-c2da-4316-8025-04d4c1e69e42","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5db282f-c2da-4316-8025-04d4c1e69e42/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-04-20T13:43:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":69890,"url":"https://lda.gov/api/v1/clients/69890/","client_id":69890,"name":"NOVOCURE INC.","general_description":"Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.","client_government_entity":null,"client_self_select":false,"state":"NH","state_display":"New Hampshire","country":"US","country_display":"United States of America","ppb_state":"NH","ppb_state_display":"New Hampshire","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-08"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":true},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"NOVOCURE GMBH","contribution":"0.00","ownership_percentage":"100.00","address":"Neuhofstrasse 21","city":"6340 Baar","state":null,"state_display":null,"country":"CH","country_display":"Switzerland","ppb_city":"6340 Baar","ppb_state":null,"ppb_state_display":null,"ppb_country":"CH","ppb_country_display":"Switzerland"},{"name":"NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)","contribution":"0.00","ownership_percentage":"100.00","address":"19, rue de Bitbourg","city":"L-1273, Luxemborg","state":null,"state_display":null,"country":"LU","country_display":"Luxembourg","ppb_city":"L-1273, Luxemborg","ppb_state":null,"ppb_state_display":null,"ppb_country":"LU","ppb_country_display":"Luxembourg"}],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b5db282f-c2da-4316-8025-04d4c1e69e42/","filing_uuid":"b5db282f-c2da-4316-8025-04d4c1e69e42","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b5db282f-c2da-4316-8025-04d4c1e69e42/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-04-20T13:43:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":69890,"url":"https://lda.gov/api/v1/clients/69890/","client_id":69890,"name":"NOVOCURE INC.","general_description":"Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.","client_government_entity":null,"client_self_select":false,"state":"NH","state_display":"New Hampshire","country":"US","country_display":"United States of America","ppb_state":"NH","ppb_state_display":"New Hampshire","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-08"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":true},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"NOVOCURE GMBH","contribution":"0.00","ownership_percentage":"100.00","address":"Neuhofstrasse 21","city":"6340 Baar","state":null,"state_display":null,"country":"CH","country_display":"Switzerland","ppb_city":"6340 Baar","ppb_state":null,"ppb_state_display":null,"ppb_country":"CH","ppb_country_display":"Switzerland"},{"name":"NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)","contribution":"0.00","ownership_percentage":"100.00","address":"19, rue de Bitbourg","city":"L-1273, Luxemborg","state":null,"state_display":null,"country":"LU","country_display":"Luxembourg","ppb_city":"L-1273, Luxemborg","ppb_state":null,"ppb_state_display":null,"ppb_country":"LU","ppb_country_display":"Luxembourg"}],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/5080ec4a-3746-469b-b0f4-555033ad40ee/","filing_uuid":"5080ec4a-3746-469b-b0f4-555033ad40ee","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/5080ec4a-3746-469b-b0f4-555033ad40ee/print/","filing_document_content_type":"text/html","income":null,"expenses":"550000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Elizabeth Sharp","dt_posted":"2026-04-20T14:39:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"222 Jacobs Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Cambridge","registrant_state":"MA","registrant_zip":"02141","registrant":{"id":31417,"url":"https://lda.gov/api/v1/registrants/31417/","house_registrant_id":30989,"name":"PHILIPS HOLDING USA, INC.","description":"Manufacturing","address_1":"222 Jacobs Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02141","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH SHARP","contact_telephone":"+1 202-940-5631","dt_updated":"2026-07-29T15:52:29.047153-04:00"},"client":{"id":138240,"url":"https://lda.gov/api/v1/clients/138240/","client_id":12,"name":"PHILIPS HOLDING USA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-04-02"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"FY2027 National Defense Authorization Act - Right to repair provisions Telehealth in DOD","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CHM","general_issue_code_display":"Chemicals/Chemical Industry","description":"EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":14,"name":"Council of Economic Advisers (CEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"S. 2983, Protecting America from Cyberthreats Act, all provisions","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/673d4471-decf-4b13-aecd-f56014c37377/","filing_uuid":"673d4471-decf-4b13-aecd-f56014c37377","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/673d4471-decf-4b13-aecd-f56014c37377/print/","filing_document_content_type":"text/html","income":null,"expenses":"490000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-04-20T15:47:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626 / H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2023 (H.R. 2408 118th Congress) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2023 (S. 1198/H.R. 2718 118th Congress) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act (S. 2287/H.R. 4425 119th Congress) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2584 118th Congress) Alleviating Barriers for Caregiving Act (S. 3109 118th Congress) Credit for Caring Act of 2025 (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon Investigation of Co-occurring Conditions across the Lifespan to Understand Down Syndrome (INCLUDE) Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025 (S. 2016/H.R. 4189 118th Congress; S. 1261/H.R. 4206 119th Congress) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Timely Access to Care Act of 2025 (S. 1816/H.R. 3514 119th Congress) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act of 2026 (H.R. 7779 119th Congress) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766 119th Congress) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343 119th Congress) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 8588, 118th Congress) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1029) Catching Up Family Caregivers Act (S. 5149 / H.R. 9764, 118th Congress) Improving Retirement Security for Family Caregivers Act (S. 5148 / H.R. 9765, 118th Congress) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565 / H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/12e75bdc-39a5-417e-8549-cb7b712f69ae/","filing_uuid":"12e75bdc-39a5-417e-8549-cb7b712f69ae","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/12e75bdc-39a5-417e-8549-cb7b712f69ae/print/","filing_document_content_type":"text/html","income":null,"expenses":"700000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-04-20T15:55:24-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to data privacy standards and transparency; and Issues related to right to repair for medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025 H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 5269 / S. 2761 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 H.R. 1406 - Lung Cancer Screening and Prevention Act of 2025; H.R. 2319 / S. 1157 - Woman and Lung Cancer Research and Preventive Services Act of 2025 H.R. 6178 - Increasing Access to Lung Cancer Research Screening Act H.R. 842 / S. 339 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to lung and breast cancer screening; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review; Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5304 / S. S587 / H. Rept. 119-271 / S. Rept. 117-55 - Labor-HHS-Education Appropriation Act, FY 2026;","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0601a2ee-d017-40f7-b169-bb31c5b9ff99/","filing_uuid":"0601a2ee-d017-40f7-b169-bb31c5b9ff99","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/0601a2ee-d017-40f7-b169-bb31c5b9ff99/print/","filing_document_content_type":"text/html","income":null,"expenses":"940000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Todd Gillenwater","dt_posted":"2026-04-20T16:05:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"950 F STREET, NW","registrant_address_2":"SUITE 500","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":24817,"url":"https://lda.gov/api/v1/registrants/24817/","house_registrant_id":31049,"name":"MEDTRONIC, INC.","description":null,"address_1":"950 F STREET, NW","address_2":"SUITE 500","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JESSICA BATTAGLIA","contact_telephone":"+1 202-442-3622","dt_updated":"2026-07-28T14:01:16.219938-04:00"},"client":{"id":132539,"url":"https://lda.gov/api/v1/clients/132539/","client_id":12,"name":"MEDTRONIC INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; H.R. 5343) Issues related to coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399; H.R. 6197) Issues related to prior authorization, including CMMI WISeR Model Issues related to DME competitive bidding Issues related to non-opioid pain therapies Issues related to transcatheter heart valves","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152337,"prefix":null,"prefix_display":null,"first_name":"ELI","nickname":null,"middle_name":null,"last_name":"KOGAN","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Joseph Crowley, NY-14","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to the taxation of multinational corporations corporations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to global supply chains including rare earth and critical minerals including S.3658 the Securing Essential and Critical U.S. Resources and Elements Minerals Act of 2026 Issues related to tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Issues related to artificial intelligence and other advanced software in health care Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152337,"prefix":null,"prefix_display":null,"first_name":"ELI","nickname":null,"middle_name":null,"last_name":"KOGAN","suffix":null,"suffix_display":null},"covered_position":"Legislative Assistant, Rep. Joseph Crowley, NY-14","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to anti-trust and competition","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to hypertension Issues related to procurement of healthcare technologies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Issues related to the National Defense Authorization Act for Fiscal Year 2027 including servicing and repair of medical devices","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to hypertension, including FY27 MilCon/Veterans Appropriations Issues related to overactive bladder and urinary incontinence, including FY27 Labor/HHS Appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Issues related to third party litigating funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6ef5f4d1-8580-4737-9874-137bce974186/","filing_uuid":"6ef5f4d1-8580-4737-9874-137bce974186","filing_type":"1A","filing_type_display":"1st Quarter - Amendment","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6ef5f4d1-8580-4737-9874-137bce974186/print/","filing_document_content_type":"text/html","income":null,"expenses":"580000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Elizabeth Sharp","dt_posted":"2026-04-23T16:26:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"222 Jacobs Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Cambridge","registrant_state":"MA","registrant_zip":"02141","registrant":{"id":31417,"url":"https://lda.gov/api/v1/registrants/31417/","house_registrant_id":30989,"name":"PHILIPS HOLDING USA, INC.","description":"Manufacturing","address_1":"222 Jacobs Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02141","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH SHARP","contact_telephone":"+1 202-940-5631","dt_updated":"2026-07-29T15:52:29.047153-04:00"},"client":{"id":138240,"url":"https://lda.gov/api/v1/clients/138240/","client_id":12,"name":"PHILIPS HOLDING USA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-04-02"},"lobbying_activities":[{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"FY2027 National Defense Authorization Act - Right to repair provisions Telehealth in DOD","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CHM","general_issue_code_display":"Chemicals/Chemical Industry","description":"EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":14,"name":"Council of Economic Advisers (CEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOM","general_issue_code_display":"Homeland Security","description":"S. 2983, Protecting America from Cyberthreats Act, all provisions","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0b16f63a-cfd7-46ca-914e-ee9212ecf6b8/","filing_uuid":"0b16f63a-cfd7-46ca-914e-ee9212ecf6b8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0b16f63a-cfd7-46ca-914e-ee9212ecf6b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"75000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Maynard Friesz","dt_posted":"2026-07-10T12:10:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"50 Commerce Dr","registrant_address_2":"Suite 90","registrant_different_address":true,"registrant_city":"Schaumburg","registrant_state":"IL","registrant_zip":"60173","registrant":{"id":401104586,"url":"https://lda.gov/api/v1/registrants/401104586/","house_registrant_id":null,"name":"CURE SMA","description":"Non-profit","address_1":"50 Commerce Dr","address_2":"Suite 90","address_3":null,"address_4":null,"city":"Schaumburg","state":"IL","state_display":"Illinois","zip":"60173","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAYNARD FRIESZ","contact_telephone":"+1 202-871-8004","dt_updated":"2026-07-10T12:05:55.658081-04:00"},"client":{"id":202103,"url":"https://lda.gov/api/v1/clients/202103/","client_id":12,"name":"CURE SMA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-08-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Research into spinal muscular atrophy, timely access to care, treatments, medical devices, and home and community-based services, Medicaid home care (paid family caregiving & self-directed care), Give Kids a Chance Act (H.R.1261/ S.932- FDA Pediatric Priority Review Voucher Program), DOD Congressionally Directed Medical Research Program & Peer-Reviewed Medical Research Program, Local Coverage Determination related to seat elevation in Group 2 standard power wheelchairs, Labor-Health and Human Services, and Education Appropriations bill, Family Caregiver Awareness, Resources, and Education (CARE) Partnerships Act, Pediatric Palliative Care Homes, National Institute on Disability, Independent Living, and Rehabilitation Research funding, Seat Elevation in Group 2 Non-Complex Power Wheelchairs, Coverage of Standing Systems in Group 3 Power Wheelchair, Competitive Bidding for Tracheostomy, Ostomy and Urological Supplies; FDA Rare Disease Patient Listening Session, Coverage of Respiratory Assist Devices (RADs) and Home Mechanical Ventilators (HMVs), Accelerating Kids Access to Care Act (H.R. 1509/S. 752, National Institutes of Health grant management process & funding; Medicaid home and community-based services, Public Law 119-21 Medicaid Community Engagement Requirements - disability and medically frail definition; Ensuring Patient Access to Critical Breakthrough Products Act (H.R. 5343), Veterans STAND Act (H.R. 6835), Veterans SPORTS Act (S. 3138) Consolidated Appropriations Act of 2026 (P.L. 119-75)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"U.S. Department of Defense Peer-Reviewed Medical Research Program Research in Spinal Muscular Atrophy, Funding for Defense Health Research Programs (Congressionally Directed Medical Research Programs and Peer Reviewed Medical Research Program), Medical Research for Our Troops Act (H.R. 3906)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"Transportation-HUD Appropriations bill, housing for people with disabilities (Sec. 811 Housing for People with Disabilities, Mainstream Housing Choice Vouchers, & Emergency Housing Vouchers), funding for disability and aging programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":35,"name":"Housing & Urban Development, Dept of (HUD)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"medical research in spinal muscular atrophy, development and approval of spinal muscular atrophy treatments, National Institutes of Health funding, U.S. Department of Defense peer reviewed research in spinal muscular atrophy, U.S. Department of Defense Congressionally Directed Medical Research Program funding, Medical Research for Our Troops Act (H.R. 3906)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Labor, Health and Human Services, and Education Appropriations bill; IDEA Full Funding Act (H.R.2598/ S.1277), IDEA enforcement and oversight, Department of Education Office of Special Education and Rehabilitative Services staffing and enforcement","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DIS","general_issue_code_display":"Disaster Planning/Emergencies","description":"Disaster Relief Medicaid Act (H.R.3990/ S.2071), disaster planning and readiness assistance for individuals with disabilities","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENG","general_issue_code_display":"Energy/Nuclear","description":"Maintain Puerto Rico Energy Resilience Fund grants for residents with SMA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":33,"name":"Energy, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health research into spinal muscular atrophy, U.S. Department of Defense Peer-Reviewed Medical Research in spinal muscular atrophy, Congressionally Directed Medical Research Program funding, Medicaid home and community-based services, housing (Sec. 811 Housing for People with Disabilities & Mainstream Housing Choice Vouchers), Defense Health Research Programs (Congressionally Directed Medical Research Programs), National Institute on Disability, Independent Living, and Rehabilitation Research funding, Labor-HHS-Education Appropriations bill, Transportation-HUD Appropriations bill, Defense Appropriations bill, Department of Education Office of Special Education and Rehabilitative Services staffing, Consolidated Appropriations Act of 2026 (P.L. 119-75), Assistive Technology Act program funding, Access Board funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":35,"name":"Housing & Urban Development, Dept of (HUD)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"CIV","general_issue_code_display":"Civil Rights/Civil Liberties","description":"Supplemental Security Income Savings Penalty Elimination Act (H.R.2540/ S.1234), SSI Restoration Act, disability marriage penalty, Marriage Equality for Disabled Adults Act (H.R. 1389), Eliminating the Marriage Penalty in SSI Act (H.R. 320/ S.73), home and community-based services, Individuals with Disabilities Act (P.L. 101-336), ENABLE Act (H.R.1436/S.627), Seat Elevation in Group 2 Non-Complex Power Wheelchairs, Coverage of Standing Systems in Power Wheelchairs, Adult Changing Tables at U.S. Capitol, Department of Education Office of Special Education and Rehabilitative Services staffing and enforcement, Public Law 119-21 Implementation, including disability and medically frail definition for Medicaid Community Engagement Requirement; Veterans STAND Act (H.R. 6835), Veterans SPORTS Act (S. 3138), ABLE Tomorrow Act, the ABLE MATCH Act, and the ABLE Direct Deposit Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"AVI","general_issue_code_display":"Aviation/Airlines/Airports","description":"FAA Reauthorization Act of 2024 (P.L. 118-63); Air Carrier Access Act (P.L. 99-435), Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Final Rule, \"Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Rule II, Transportation-HUD Appropriations bill, disability-related air travel complaints & aviation consumer protections","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid home and community-based services, Medicaid caregiving services, Medicaid funding, 2025 Budget Resolution, durable medical equipment, Pediatric Palliative Care Homes, H.R. 1, Think Differently Database Act (P.L. 118-225), Labor-HHS-Education Appropriations bill, Public Law 119-21 Implementation, including disability and medically frail definition for Medicaid Community Engagement Requirement; Seat Elevation in Group 2 Non-Complex Power Wheelchairs, Coverage of Standing Systems in Group 3 Power Wheelchair, Competitive Bidding for Tracheostomy, Ostomy and Urological Supplies, Local Coverage Determination related to seat elevation in Group 2 standard power wheelchairs,","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"ENABLE Act (H.R.1436/ S.627), Mobility Means Freedom Act (H.R.2320), Achieving a Better Life Experience (ABLE) Act (P.L. 113-295), H.R. 1, ABLE Tomorrow Act, the ABLE MATCH Act, and the ABLE Direct Deposit Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRA","general_issue_code_display":"Transportation","description":"FAA Reauthorization Act of 2024 (P.L. 118-63); Air Carrier Access Act (P.L. 99-435), Ensuring Safe Accommodations for Air Travelers with Disabilities Using Wheelchairs Final Rule, Disability Access to Transportation Act, accessibility in community transportation, Automated Vehicle (AV) Deployment and Research, Transportation-HUD Appropriations bill, surface transportation reauthorization, BUILD America 250 Act (H.R. 8870), automated driving system-equipped vehicle federal safety standards","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"BELLISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71876,"prefix":null,"prefix_display":null,"first_name":"MAYNARD","nickname":null,"middle_name":null,"last_name":"FRIESZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":172,"name":"Federal Aviation Administration (FAA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":175,"name":"Natl Highway Traffic Safety Administration (NHTSA)"},{"id":1,"name":"SENATE"},{"id":40,"name":"Transportation, Dept of (DOT)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8789d0e9-3c75-4b52-b83b-6bdd8f967db8/","filing_uuid":"8789d0e9-3c75-4b52-b83b-6bdd8f967db8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/8789d0e9-3c75-4b52-b83b-6bdd8f967db8/print/","filing_document_content_type":"text/html","income":null,"expenses":"120000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Allison Giles","dt_posted":"2026-07-13T10:11:00-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"P.O. Box 6924","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22206","registrant":{"id":87654,"url":"https://lda.gov/api/v1/registrants/87654/","house_registrant_id":36626,"name":"THE COOK GROUP INC.","description":"Medical device manufacturer.","address_1":"P.O. Box 6924","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22206","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALLISON GILES","contact_telephone":"+1 202-631-5577","dt_updated":"2026-07-21T16:23:20.759644-04:00"},"client":{"id":173616,"url":"https://lda.gov/api/v1/clients/173616/","client_id":12,"name":"THE COOK GROUP INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Graduate Medical Education (GME): -\"Resident Physician Shortage Reduction Act of 2025\" (H.R. 4731) which would increase GME positions in rural areas; -the \"Public Health and Bio-Preparedness Workforce Loan Repayment Reauthorization Act of 2025\" (H.R. 4445) FDA Modernization: -Modeling non-animal studies for medtech -Biotechnology: reduce regulatory barriers; align public-private investment -Medical Device Electronic Labeling Act (IFU) bill (FDA issue) (H.R. 1539) FDA Reform: -Medical device shortage reporting; domestic production of medical products; use of real-world data (RWD) and real-world evidence (RWE) Nursing Workforce Shortage Artificial Intelligence (AI): -Presidential E.O. 14179 setting forth national policy framework for AI and Congressional action to provide preemption of conflicting state requirements, safe and efficient adoption of AI. Right-to-Repair provision in House NDAA H.R.4784/H.R. 8800 broadly would impact FDA regulated medical devices","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax incentives to promote U.S. manufacturing; construction of workforce housing; new market tax credit (H.R. 1103)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Workforce Development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariffs levied by the Administration; Dept. of Commerce Bureau of Industry and Security: Request for Comments on Section 232 Investigation of Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices Tariff Trade Act of 2025 (S. 1272/H.R.2665)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":107,"name":"Bureau of Industry and Security (BIS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SPO","general_issue_code_display":"Sports/Athletics","description":"Name, Image and Likeness (NIL) issue: \"SCORE Act\" (H.R. 4312)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Reimbursement: Medicare Coverage of Breakthrough Technologies (S. 1717/H.R. 5343); Transitional Coverage for Emerging Technologies (TCET)/Medicare Coverage for Innovative Technology (MCIT); supplies and services incident to a physician's services reimbursement. Medicare coverage of telehealth flexibilities CMS NPRM IPPS proposal to repeal New Technology Add on Payment (NTAP) and Transitional Pass-Through pathway for FDA Breakthrough Devices; proposal for adoption of unique device identifier (UDI) capture measure under the Medicare Promoting Interoperability Program. Medicare payment for FTE residents training in rural areas, \"Rural Physician Workforce Production Act of 2025\" (H.R. 1153)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CHM","general_issue_code_display":"Chemicals/Chemical Industry","description":"PFAS issues: Fluoro Polymers [Per- and polyfluoroalkyl] (PFAS) type(s) of substances used in medical devices","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/bd0f4f47-89e8-41e3-8649-b1381e4b9d97/","filing_uuid":"bd0f4f47-89e8-41e3-8649-b1381e4b9d97","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/bd0f4f47-89e8-41e3-8649-b1381e4b9d97/print/","filing_document_content_type":"text/html","income":null,"expenses":"90000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brenna Leamer","dt_posted":"2026-07-15T13:35:12-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"901 F St., NW Suite 610","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":18411,"url":"https://lda.gov/api/v1/registrants/18411/","house_registrant_id":31167,"name":"F. HOFFMANN-LA ROCHE LTD, AND ITS AFFILIATES","description":null,"address_1":"901 F St., NW Suite 610","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRENNA LEAMER","contact_telephone":"+1 317-282-3252","dt_updated":"2026-07-15T13:50:56.942960-04:00"},"client":{"id":123844,"url":"https://lda.gov/api/v1/clients/123844/","client_id":12,"name":"F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Access to and reimbursement of diagnostics in the Medicare program. H.R. 5269 / S. 2761 Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare reimbursement of Clinical Laboratory Fee Schedule (CLFS), specifically reforms to address payment cuts resulting from the Protecting Access to Medicare Act (PAMA) 2014. S.1717 / H.R.5343 The Ensuring Patient Access to Critical Breakthrough Products Act. Issues related to Medicare coverage and reimbursement for FDA-designated breakthrough medical devices, focusing on establishing transitional coverage period. Issues related to Tariffs and Department of Commerce 232 investigation on Medical Technologies FY2027 Appropriations for Labor, Health and Human Services, Education, and Related Agencies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOR","general_issue_code_display":"Foreign Relations","description":"(FOR) HIV Testing in the President's Emergency Plan for AIDS Relief, including funding to support PEPFAR laboratory services and testing in FY2027 Appropriations for National Security, Department of State, and Related Programs, and PEPFAR Reauthorization in the FY2026 State Department Reauthorization (H.R.5300 - Department of State Policy Provisions Act)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"(HCR) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Breast and Cervical Cancer, Alzheimer's and Influenza Preparedness","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"(MED) Issues related to public health emergency preparedness, including Pandemic All-Hazards Preparedness Act and H.R.1108 The Diagnostics Testing Preparedness Plan Act. Issues related to the FDA regulation of diagnostics. Issues related to diagnostics to support Preeclampsia, Breast and Cervical Cancer, Alzheimer's and Influenza Preparedness Clinical Lab Fee Schedule reform, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act H.R. 5269 / S. 2761 and Medicare coverage of FDA approved breakthrough diagnostics, S.1717 / H.R. 5343 The Ensuring Patient Access to Critical Breakthrough","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107364,"prefix":null,"prefix_display":null,"first_name":"BRENNA","nickname":null,"middle_name":"MARIE","last_name":"LEAMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":57673,"prefix":"mr","prefix_display":"MR.","first_name":"RUSSELL","nickname":null,"middle_name":"CONWELL","last_name":"RING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":82599,"prefix":null,"prefix_display":null,"first_name":"NANCY","nickname":null,"middle_name":null,"last_name":"CARLTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144984,"prefix":null,"prefix_display":null,"first_name":"CASSANDRA","nickname":null,"middle_name":null,"last_name":"RICCI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2590168e-b6bc-441e-8c72-bd77282ea7ec/","filing_uuid":"2590168e-b6bc-441e-8c72-bd77282ea7ec","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/2590168e-b6bc-441e-8c72-bd77282ea7ec/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Greg D'Angelo","dt_posted":"2026-07-15T15:53:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"601 13th St. NW","registrant_address_2":"Suite 250 N","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":293335,"url":"https://lda.gov/api/v1/registrants/293335/","house_registrant_id":37338,"name":"THE NICKLES GROUP, LLC","description":"Consulting firm.","address_1":"601 13th St. NW","address_2":"Suite 250 N","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATHLEEN MCGHEE","contact_telephone":"+1 202-742-6990","dt_updated":"2026-07-06T11:19:03.627222-04:00"},"client":{"id":61144,"url":"https://lda.gov/api/v1/clients/61144/","client_id":61144,"name":"ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED)","general_description":"Medical technology trade association.","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage of breakthrough technologies. Issues related to the RAPID coverage pathway. S. 1717 / H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act of 2025. Issues related to Medicare durable medical equipment competitive bidding and coverage of diabetes technologies. The FY2027 IPPS proposed rule and issues related to new technology add-on payments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103387,"prefix":null,"prefix_display":null,"first_name":"BRETT","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":89965,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":null,"last_name":"D'ANGELO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":26331,"prefix":null,"prefix_display":null,"first_name":"MARY","nickname":null,"middle_name":"BETH","last_name":"SAVARY TAYLOR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":20062,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"JONES HENSLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150500,"prefix":null,"prefix_display":null,"first_name":"MOLLY","nickname":null,"middle_name":null,"last_name":"FROMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e90b5b71-9df7-4677-bc84-c658d4a8e9ea/","filing_uuid":"e90b5b71-9df7-4677-bc84-c658d4a8e9ea","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/e90b5b71-9df7-4677-bc84-c658d4a8e9ea/print/","filing_document_content_type":"text/html","income":null,"expenses":"642000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Steven LaPierre","dt_posted":"2026-07-17T19:12:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 PENNSYLVANIA AVENUE, NW","registrant_address_2":"SUITE 925","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":66716,"url":"https://lda.gov/api/v1/registrants/66716/","house_registrant_id":35567,"name":"BOSTON SCIENTIFIC CORPORATION","description":null,"address_1":"1455 PENNSYLVANIA AVENUE, NW","address_2":"SUITE 925","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"STEVEN N. LAPIERRE","contact_telephone":"","dt_updated":"2026-07-24T11:29:57.860946-04:00"},"client":{"id":163613,"url":"https://lda.gov/api/v1/clients/163613/","client_id":12,"name":"BOSTON SCIENTIFIC CORPORATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2001-06-01"},"lobbying_activities":[{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"EPA Rulemaking Restricting Ethylene Oxide (ETO) - Proposed rulemaking to place more-stringent limits on emissions and institute new monitoring requirements for ethylene oxide (ETO). Advocacy efforts include educating lawmakers on the importance of ETO in the sterilization of medical devices and potential shortages of sterile medical devices if EPA's proposed changes are enacted.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Ensuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communities Act - Advocacy for reauthorization of the SUPPORT Act, specifically for FDA approved alternative treatments for Chronic Pain, and medical devices role to address the opioid epidemic. Starting work on the Food and Drug Omnibus Reform Act of 2026 (Public Law 117-328) - advocacy efforts on Medical Device User Fee Amendments (MDUFA) reauthorization, riders, and device shortages. Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) (Public Law 109-417) - advocacy on risk mitigation plans and voluntary shortage reporting related to medical device supply chains and advocacy for medical research and to foster a new era of medical innovation and prepare for future pandemics and promote health equity. Support passage of the Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 - Senate (S. 1031) & (H.R. 2120). This legislation would increase access to patient care, enhance the quality of cancer treatments, encourage innovation, reduce disparities for rural and underserved patients, and lower patient costs by saving Medicare about $200 million over 10 years. The WISeR Model (Wasteful and Inappropriate Service Reduction Model) - Advocacy efforts on inclusions in CMS' WISeR model, which is aimed at reducing inappropriate care and preventing improper payments under Medicare Part B by refining prior authorization processes for traditional fee-for-service Medicare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Medical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives, specifically H.R.6835. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. Take Care of American Veterans Act: Specifically advocating for modernizing the VA's prosthetics and implant procurement program by increasing resources, expanding clinical and procurement expertise, and requiring implementation of a nationwide electronic ordering system.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"OECD 2 Pillar Framework Implementation - International tax provisions specifically regarding the global minimum tax, including the Defending American Jobs Act (H.R. 591) and the Unfair Tax Prevention Act (H.R.2423), legislation regarding extraterritorial taxation and completion/implementation of the G7 side-by-side agreement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Supply Chain - advocacy efforts on topics that could potentially impact the medical device supply chain such as decisions made by the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party, outbound investments, raw materials, components, export controls, and shortage/supply chain resiliency reporting regulations. Submitted comments for the U.S. Dept of Commerce's investigation to determine the effects on the national security of imports of medical equipment including medical devices. Discussed the unique aspects and critical contributions of the U.S. medical technology sector as related to tariffs and other trade measures on imported medical devices and components and our support for policies that do not harm domestic manufacturing and global competition in the sector.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to the U.S. House discussion draft of the Great American AI Act (GAAIA) - Advocacy and education efforts on the importance of FDA retaining regulatory authority over AI used in medical devices, and on redundant or potentially harmful regulations that could impair patient access to devices or hinder innovation. Issues related to SECURE Data Act (H.R. 8413) - Advocacy for the inclusion of healthcare-related carveouts with exemptions for HIPAA covered entities and business associates, health records, and certain clinical research and patient-safety data. Also, advocacy for the inclusion of language preempting state frameworks by establishing a single federal standard.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Issues related to FY2027 National Defense Authorization Act (NDAA) (S. 4784 & H.R. 8800) - Advocacy efforts on right to repair (RTR) proposals impacting servicing and repair of medical devices. Specifically, the Reform of Technical Data and Software Rights to Support Competition, Sustainment, and Readiness (section 861 of H.R. 8800), the Modifications to Technical Data Rights (section 804 of S. 4784), and other provisions related to healthcare and proprietary data.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":59163,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"LEE","last_name":"TIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144221,"prefix":"ms","prefix_display":"MS.","first_name":"WHITNEY","nickname":null,"middle_name":"B","last_name":"CRAIG","suffix":"jd","suffix_display":"JD"},"covered_position":null,"new":false},{"lobbyist":{"id":41151,"prefix":"mr","prefix_display":"MR.","first_name":"STEVEN","nickname":null,"middle_name":"NEIL","last_name":"LAPIERRE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142225,"prefix":null,"prefix_display":null,"first_name":"CAMERON","nickname":null,"middle_name":null,"last_name":"BAKER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/82d0e925-8f96-4e10-bb9b-ced64071378f/","filing_uuid":"82d0e925-8f96-4e10-bb9b-ced64071378f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/82d0e925-8f96-4e10-bb9b-ced64071378f/print/","filing_document_content_type":"text/html","income":null,"expenses":"1800000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Robert Egge","dt_posted":"2026-07-20T12:42:58-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th Street, NW","registrant_address_2":"Suite 500","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":1262,"url":"https://lda.gov/api/v1/registrants/1262/","house_registrant_id":30526,"name":"ALZHEIMER'S ASSOCIATION","description":null,"address_1":"655 15th Street, NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROBERT EGGE","contact_telephone":"+1 202-638-8660","dt_updated":"2026-07-30T10:03:36.870640-04:00"},"client":{"id":102599,"url":"https://lda.gov/api/v1/clients/102599/","client_id":12,"name":"ALZHEIMER'S ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-10"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"NAPA Reauthorization Act (P.L. 118-92) Alzheimers Accountability and Investment Act (P.L. 118-93) Comprehensive Care for Alzheimers Act (S. 626/H.R. 1637 118th Congress) Reauthorization of the BOLD Infrastructure for Alzheimer's Act (P.L. 115-406) BOLD Reauthorization Act (P.L. 118-142) Accelerating Access to Dementia & Alzheimers Provider Training (AADAPT) Act (H.R. 3747 / S. 4036) The Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act (P.L. 118-210) VA Clinician Appreciation, Recruitment, Education, Expansion, and Retention Support (CAREERS) Act of 2023 (S. 10 118th Congress) Access to Innovative Treatments Act of 2026 (H.R. 9418) Mandating Exclusive Review of Individual Treatments (MERIT) Act of 2023 (H.R. 133 118th Congress) Elder Justice Reauthorization and Modernization Act of 2026 (H.R. 8060) Expanding Veterans Options for Long-Term Care Act (S. 495/H.R.1815 118th Congress) Palliative Care and Hospice Education and Training Act of 2023 (S. 2287/H.R. 4425) Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023 (S. 1544/H.R. 1199 118th Congress) Supporting Our Seniors Act (S. 2762) Alleviating Barriers for Caregiving Act (S. 1227/H.R. 2491) Credit for Caring Act (S. 925/H.R. 2036) Lifespan Respite Care Reauthorization Act (S.830/H.R.2560) DeOndra Dixon INCLUDE Project Act of 2025 (H.R. 3491/S. 1838) Paid Family and Medical Leave Tax Credit Extension and Enhancement Act (S. 400/H.R. 996) Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act (S. 1261/H.R. 4206) PACE Part D Choice Act (S. 1703/H.R. 3549 118th Congress) Improving Seniors' Access to Timely Care Act of 2025 (S. 1816/H.R. 3514) Harmonizing Environmental Analyses and Launching Therapeutic Hubs to Yield Bolstered Research and Innovation in Neurological Science (HEALTHY BRAINS) Act (H.R. 7779) Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act of 2023(S. 526/H.R. 1092) Essential Caregivers Act (H.R. 6766) Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717/H.R. 5343) The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S.2761/H.R.5269) Linking Seniors to Needed Legal Services Act (H.R. 6728) Amending the Rules of the House of Representatives to establish a Permanent Select Committee on Aging (H. Res. 1013) Catching Up Family Caregivers Act of 2026 (S. 4291/H.R. 8273) Improving Retirement Security for Family Caregivers Act of 2026 (S. 4291 /H.R. 8273) Charitable Act (S. 317/H.R. 801) Alzheimers Law Enforcement Education Act of 2025 (H.R. 3389) Health Tech Investment Act (S.1399) One Big Beautiful Bill Act (H.R. 1) Older Americans Act Reauthorization Act of 2025 (S. 2120) Lowering Costs for Caregivers Act of 2025 (S. 1565/H.R. 138) Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act (S. 2761 / H.R. 5269) Enhanced Alerts for Missing Loved Ones with Disabilities Act of 2026 (S. 4670/H.R. 9118) Alzheimers Screening and Prevention Act (H.R. 6130/S. 3267) Other matters related to disaster preparedness and older adults, public health emergencies, public health preparedness and response, telehealth, health disparities, and older Americans/people with disabilities in all phases of emergencies Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease Other matters related to care payment models, including the GUIDE model Other matters related to Medicare care planning code 99483 Other matters related to health care workforce shortages Other matters related to home- and community-based services Other matters related to disaster preparedness and older adults Other matters related to Social Security Other matters related to technology-enabled collaborative learning and capacity-building models (Project ECHO) Other matters related to beta-amyloid PET scans Other matters related to selected diagnoses and services rendered under ICD-10 Other matters related to caregiving Other matters related to medical devices Other matters related to rural health Other matters related to veterans' health and traumatic brain injury (TBI) Other matters related to Tricare Other matters related to research Other matters related to biomarkers including blood-based tests and cerebral spinal fluid (CSF) Other matters related to public health Other matters related to elder justice, abuse and neglect Other matters related to Medicaid Other matters related to nonprofit infrastructure and operations Other matters related to the National Plan to Address Alzheimer's Disease and the NAPA Advisory Council Other matters related to the Alzheimer's Screening and Prevention (ASAP) Act Other matters related to the reauthorization of the Alzheimers semipostal stamp Other matters related to brain health, risk reduction, and the U.S. POINTER study and results Other matters related to biomarker disclosure and discrimination (Office of Civil Rights at HHS) Other matters related to long-term care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":114396,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"HEATH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":91,"name":"Social Security Administration (SSA)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Matters related to Fiscal Years 2026 and 2027 appropriations for Alzheimers funding at the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, Health Resources and Services Administration, Administration for Community Living, Department of Defense, and Indian Health Service Matters related to Fiscal Year 2026 and 2027 appropriations language reflecting scientific advances in Alzheimers at the Food and Drug Administration and the Centers for Medicare & Medicaid Services Appropriations related to OAA Title III-C Nutrition Program and appropriations related to [88 FR 80085] Initiative on Women's Health Research Other matters related to Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease Other matters related to beta-amyloid PET scans Other matters related to diagnostics for Alzheimers disease and other dementia Other matters related to brain health and risk reduction Other matters related to clinical trials","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55648,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"CONANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140279,"prefix":"ms","prefix_display":"MS.","first_name":"LAURA","nickname":null,"middle_name":null,"last_name":"THORNHILL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67551,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"POLLACK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141524,"prefix":"mrs","prefix_display":"MRS.","first_name":"MARY","nickname":null,"middle_name":"AGNES","last_name":"GERMILLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145182,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"OSUNA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145183,"prefix":null,"prefix_display":null,"first_name":"ZOE","nickname":null,"middle_name":null,"last_name":"SALZBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152388,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"WING","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[{"name":"ALZHEIMERS IMPACT MOVEMENT (AIM)","url":"https://alzimpact.org","address_1":"655 15th Street, NW, Ste. 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_city":null,"ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America"}]},{"url":"https://lda.gov/api/v1/filings/43838072-033e-49a4-86fe-b0a0576ba05d/","filing_uuid":"43838072-033e-49a4-86fe-b0a0576ba05d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/43838072-033e-49a4-86fe-b0a0576ba05d/print/","filing_document_content_type":"text/html","income":null,"expenses":"971000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Greg Crist","dt_posted":"2026-07-20T14:50:33-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1301 PENNSYLVANIA AVENUE, N.W., SUITE 400","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":17831,"url":"https://lda.gov/api/v1/registrants/17831/","house_registrant_id":31001,"name":"ADVANCED MEDICAL TECHNOLOGY ASSN","description":null,"address_1":"1301 PENNSYLVANIA AVENUE, N.W., SUITE 400","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREG CRIST","contact_telephone":"+1 202-434-7240","dt_updated":"2026-07-30T14:15:38.691802-04:00"},"client":{"id":123312,"url":"https://lda.gov/api/v1/clients/123312/","client_id":12,"name":"ADVANCED MEDICAL TECHNOLOGY ASSN","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to coverage of telehealth services Issues related to Medicare coverage for digital health technologies - S. 1399/H.R. 6197 Issues related to S. 1717/H.R. 5343 Ensuring Patient Access to Critical Breakthrough Products Act Issues related to S. 2761/H.R. 5269 Lab Payments and Results Act Issues related to Medicare coverage of FDA's breakthrough devices Issues related to coverage of diabetes devices and supplies Issues related to Home Health Rule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to Privacy Legislation Issues related to remanufacturing and servicing medical devices Issues related to the medical supply chain Issues related to the competitiveness of the medtech industry and the impact of Federal Policies Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to coverage and reimbursement of diagnostic tests Issues related to the use of Artificial Intelligence Issues related to MDUFA Reauthorization Issues related to PFAS Chemical regulation HR 1539 - the Medical Device Electronic Labeling Act Issues related to National Defense Authorization Act Issues related to FDA regulation of diagnostic tests Issues related to the Countering CCP Act (S. 4939) Issues related to the Health Care Cybersecurity and Resiliency Act of 2025 (S. 3315)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":49,"name":"Environmental Protection Agency (EPA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Issues related to appropriations and user fee funding for the Food and Drug Administration","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to small business taxes","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on medical devices United States-Mexico-Canada Agreement (USMCA) Global Trade and EU Tariffs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":41,"name":"Treasury, Dept of"},{"id":22,"name":"U.S. Trade Representative (USTR)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Issues related to the reauthorization of the Small Business Innovation Research (SBIR) program. Issues related to small business taxes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71361,"prefix":null,"prefix_display":null,"first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"WALSH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71254,"prefix":null,"prefix_display":null,"first_name":"GREG","nickname":null,"middle_name":"MICHAEL","last_name":"CRIST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":72429,"prefix":null,"prefix_display":null,"first_name":"SARAH","nickname":null,"middle_name":null,"last_name":"KILLEEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":105658,"prefix":null,"prefix_display":null,"first_name":"KIM","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153989,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"TOMASELLO","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":140465,"prefix":null,"prefix_display":null,"first_name":"NICK","nickname":null,"middle_name":null,"last_name":"HALSTED","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3317cc02-c918-4b2f-8f5a-fa009bf5ee65/","filing_uuid":"3317cc02-c918-4b2f-8f5a-fa009bf5ee65","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3317cc02-c918-4b2f-8f5a-fa009bf5ee65/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-07-20T15:17:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":69890,"url":"https://lda.gov/api/v1/clients/69890/","client_id":69890,"name":"NOVOCURE INC.","general_description":"Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.","client_government_entity":null,"client_self_select":false,"state":"NH","state_display":"New Hampshire","country":"US","country_display":"United States of America","ppb_state":"NH","ppb_state_display":"New Hampshire","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-08"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"NOVOCURE GMBH","contribution":"0.00","ownership_percentage":"100.00","address":"Neuhofstrasse 21","city":"6340 Baar","state":null,"state_display":null,"country":"CH","country_display":"Switzerland","ppb_city":"6340 Baar","ppb_state":null,"ppb_state_display":null,"ppb_country":"CH","ppb_country_display":"Switzerland"},{"name":"NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)","contribution":"0.00","ownership_percentage":"100.00","address":"19, rue de Bitbourg","city":"L-1273, Luxemborg","state":null,"state_display":null,"country":"LU","country_display":"Luxembourg","ppb_city":"L-1273, Luxemborg","ppb_state":null,"ppb_state_display":null,"ppb_country":"LU","ppb_country_display":"Luxembourg"}],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3317cc02-c918-4b2f-8f5a-fa009bf5ee65/","filing_uuid":"3317cc02-c918-4b2f-8f5a-fa009bf5ee65","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3317cc02-c918-4b2f-8f5a-fa009bf5ee65/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Isabella Quinn","dt_posted":"2026-07-20T15:17:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1201 Pennsylvania Avenue, NW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":41454,"url":"https://lda.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":69890,"url":"https://lda.gov/api/v1/clients/69890/","client_id":69890,"name":"NOVOCURE INC.","general_description":"Commercial stage oncology dedicated to advancement of TTF therapy to treat solid tumors.","client_government_entity":null,"client_self_select":false,"state":"NH","state_display":"New Hampshire","country":"US","country_display":"United States of America","ppb_state":"NH","ppb_state_display":"New Hampshire","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-10-08"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Breakthrough pathway bill (H.R. 5343, S. 1717), CMS reimbursement of medical devices generally, and FDA issues related to medical devices.","foreign_entity_issues":"Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144121,"prefix":null,"prefix_display":null,"first_name":"JEANNE","nickname":null,"middle_name":null,"last_name":"HAGGERTY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member","new":false},{"lobbyist":{"id":149999,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":null,"middle_name":null,"last_name":"BUTORA","suffix":null,"suffix_display":null},"covered_position":"Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess","new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141323,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"ZIEGLER","suffix":null,"suffix_display":null},"covered_position":"Executive Director, Republican Study Committee; Legislative Director for Rep Doug Lamborn, Policy Director; Speaker Mike Johnson","new":false},{"lobbyist":{"id":148559,"prefix":"mr","prefix_display":"MR.","first_name":"JOSHUA","nickname":null,"middle_name":"DAVID","last_name":"FENDRICK","suffix":null,"suffix_display":null},"covered_position":"Staff Assistant, Legislative Correspondent, and Legislative Aide, Sen. Gary C. Peters; Economic Policy Adviser, Rep. Josh Gottheimer; Economic Policy Adviser, Sen. Gary C. Peters","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[{"name":"NOVOCURE GMBH","contribution":"0.00","ownership_percentage":"100.00","address":"Neuhofstrasse 21","city":"6340 Baar","state":null,"state_display":null,"country":"CH","country_display":"Switzerland","ppb_city":"6340 Baar","ppb_state":null,"ppb_state_display":null,"ppb_country":"CH","ppb_country_display":"Switzerland"},{"name":"NOVOCURE LUXEMBOURG S.A.R.L. (OWNS 100% OF NOVOCURE GMBH)","contribution":"0.00","ownership_percentage":"100.00","address":"19, rue de Bitbourg","city":"L-1273, Luxemborg","state":null,"state_display":null,"country":"LU","country_display":"Luxembourg","ppb_city":"L-1273, Luxemborg","ppb_state":null,"ppb_state_display":null,"ppb_country":"LU","ppb_country_display":"Luxembourg"}],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/799e5a99-25ab-4e63-ab62-1b4c5261b642/","filing_uuid":"799e5a99-25ab-4e63-ab62-1b4c5261b642","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/799e5a99-25ab-4e63-ab62-1b4c5261b642/print/","filing_document_content_type":"text/html","income":null,"expenses":"860000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Elizabeth Kegler","dt_posted":"2026-07-20T16:14:09-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"801 Pennsylvania Avenue, NW","registrant_address_2":"Suite 520","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401105966,"url":"https://lda.gov/api/v1/registrants/401105966/","house_registrant_id":null,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","description":"Healthcare diagnostics","address_1":"801 Pennsylvania Avenue, NW","address_2":"Suite 520","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH KEGLER","contact_telephone":"+1 484-323-1671","dt_updated":"2026-07-29T10:30:26.251926-04:00"},"client":{"id":208991,"url":"https://lda.gov/api/v1/clients/208991/","client_id":12,"name":"SIEMENS MEDICAL SOLUTIONS USA, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices; Issues related to Artificial Intelligence for medical devices; Issues related to the right to repair for medical devices; Issues related to 21 CFR Part 212 requirements good and safe manufacturing or radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 5343 / S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; H.R. 6197 / S. 1399 - Health Tech Investment Act; H.R. 4417 / S. 2927 - Mobile Cancer Screening Act; S. 1031 / H.R. 2120 - ROCR Value Based Program Act; H.R. 5269 / S. 2761 - RESULTS Act; and H.R. 2477, S. 1168 - Portable Ultrasound Reimbursement Equity Act of 2025. Issues related to access to care for new medical device technology in rural and underserved areas; and Issues related to Medicare reimbursement rates, including for mobile stroke units and in relation to artificial intelligence and in relation to radiopharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Implementation of P. L. No 116-113 United States-Mexico-Canada Agreement Implementation Act - issues related to joint review. Issues related to medical supply chains and procurement; Issues related to critical minerals supply chains and production; and Issues related to international trade.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Implementation of P. L. 87-794 - Trade Expansion Act - issues related to domestic supply chain considerations for medical devices in regard to Section 232 investigations; and Implementation of P.L. 93-618 - Trade Act - issues related to domestic supply chain considerations for medical devices in regards to Section 301 investigations and reciprocal tariffs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 8646 / H. Rept. 119-632 / H. Res. 1333 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; and H.R. 9260 / H. Rept. 119-696 - Department of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act of 2027.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 8800 / H. Res. 1398 / S. 4784 - National Defense Authorization Act for Fiscal Year 2027-Issues related to right to repair for medical devices. Issues related to Veterans Affairs healthcare.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143008,"prefix":"mrs","prefix_display":"MRS.","first_name":"CATHERINE","nickname":null,"middle_name":"HANSEN","last_name":"NABAVI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144510,"prefix":null,"prefix_display":null,"first_name":"AARON","nickname":null,"middle_name":null,"last_name":"HUNTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152304,"prefix":"ms","prefix_display":"MS.","first_name":"ELIZABETH","nickname":null,"middle_name":"RAYE","last_name":"KEGLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150471,"prefix":"ms","prefix_display":"MS.","first_name":"SARAH","nickname":null,"middle_name":"ELIZABETH","last_name":"GIANNI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/1f83cd21-b004-44fa-b4fb-14775e4033d5/","filing_uuid":"1f83cd21-b004-44fa-b4fb-14775e4033d5","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/1f83cd21-b004-44fa-b4fb-14775e4033d5/print/","filing_document_content_type":"text/html","income":null,"expenses":"640000.00","expenses_method":"C","expenses_method_display":"C","posted_by_name":"Elizabeth Sharp","dt_posted":"2026-07-20T16:31:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"222 Jacobs Street","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Cambridge","registrant_state":"MA","registrant_zip":"02141","registrant":{"id":31417,"url":"https://lda.gov/api/v1/registrants/31417/","house_registrant_id":30989,"name":"PHILIPS HOLDING USA, INC.","description":"Manufacturing","address_1":"222 Jacobs Street","address_2":null,"address_3":null,"address_4":null,"city":"Cambridge","state":"MA","state_display":"Massachusetts","zip":"02141","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ELIZABETH SHARP","contact_telephone":"+1 202-940-5631","dt_updated":"2026-07-29T15:52:29.047153-04:00"},"client":{"id":138240,"url":"https://lda.gov/api/v1/clients/138240/","client_id":12,"name":"PHILIPS HOLDING USA INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-04-02"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2027 Veterans Affairs Appropriations, in general FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"S. 4784, FY27 National Defense Authorization Act (Sec. 804) and H.R. 8800, FY27 National Defense Authorization Act (Sec. 861, Sec. 862) Telehealth in DOD","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":107285,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":"JOHN","last_name":"SHUMAN-TIMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":14,"name":"Council of Economic Advisers (CEA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1219, Oral Health Products Inclusion Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150641,"prefix":null,"prefix_display":null,"first_name":"RICHARD","nickname":null,"middle_name":"PETER","last_name":"MERSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof S. 4519, the Medical Device Electronic Labeling Act (whole bill) and H.R. 1539, the Medical Device Electronic Labeling Act (whole bill)","foreign_entity_issues":"The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.","lobbyists":[{"lobbyist":{"id":66351,"prefix":null,"prefix_display":null,"first_name":"MONICA","nickname":null,"middle_name":null,"last_name":"VOLANTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146185,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"PIKA SHARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}